New Parkinson’s Drug Combines Immediate and Slow Release
The Parkinson’s disease combination drug Hopledo (levodopa–carbidopa, Zambon S.p.A.) has received a positive opinion by the European Medicines Agency (EMA). Hopledo’s components, levodopa and carbidopa, are established Parkinson’s drugs that are often combined. The new formulation consists of modified-release hard capsules that contain both immediate-release granules and extended-release beads. The immediate-release granules consist of levodopa…
